Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
| Sales | 1,031,753 | 847,522 | 840,883 | 769,432 | 593,749 |
| Cost of Goods | 188,158 | 161,907 | 151,305 | 129,567 | 98,581 |
| Gross Profit | 843,595 | 685,615 | 689,578 | 639,865 | 495,168 |
| Operating Expenses | 703,033 | 456,965 | 440,664 | 415,620 | 338,612 |
| Operating Income | 140,720 | 229,557 | 249,219 | 224,812 | 157,137 |
| Other Income | 49,840 | 58,663 | 7,606 | 38,548 | 3,300 |
| Pre-tax Income | 190,560 | 288,220 | 256,825 | 263,360 | 160,437 |
| Income Tax | 54,055 | 62,695 | 53,816 | 4,344 | 48,267 |
| Net Income Continuous | 136,505 | 225,525 | 203,009 | 259,016 | 112,170 |
| Net Income | $136,505 | $225,525 | $203,009 | $259,016 | $112,170 |
| EPS Basic Total Ops | 3.00 | 5.00 | 4.49 | 5.77 | 2.54 |
| EPS Basic Continuous Ops | 3.00 | 5.00 | 4.49 | 5.77 | 2.54 |
| EPS Diluted Total Ops | 2.98 | 4.94 | 4.43 | 5.61 | 2.45 |
| EPS Diluted Continuous Ops | 2.98 | 4.94 | 4.43 | 5.61 | 2.45 |
| EPS Diluted Before Non-Recurring Items | 4.44 | 4.94 | 4.74 | 3.60 | 2.45 |
| EBITDA(a) | $168,809 | $253,654 | $269,649 | $238,933 | $168,142 |